Kiora Pharmaceuticals KPRX
NASDAQ KPRX
$2.34 -0.01 (-0.43%)
As of: Oct 21, 2026 · 3:59 PM EDT

Kiora Pharmaceuticals (KPRX) Notes Payables (2014 - 2020)

Updated

Kiora Pharmaceuticals (KPRX) recorded Notes Payables of $212,281 in Q4 2020.

Analysis

Kiora Pharmaceuticals (KPRX) Notes Payables (2014 - 2020) Analysis & Trends

  • The Q4 2020 figure is the highest quarterly Notes Payables since Q4 2014.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn
10 Kiora Pharmaceuticals 14.34 Mn -52.98 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2020 212,281.00
Dec 31, 2014 3.21 Mn
API Access

Kiora Pharmaceuticals Notes Payables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=notes-payables&ticker=KPRX&period=max&api_key=YOUR_API_KEY